Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

August 31, 2015

Infective Endocarditis Facts and Figures

 
Electron micrograph (SEM) of methicillin-resistant Staphylococcus aureus bacteria (MRSA);
Magnification 2363x.

 

Infective Endocarditis1
  • The prevalence of cardiac device infections in patients with S. aureus bacteremia (SAB) is approximately 50%.
  • The prevalence of infective endocarditis in SAB patients ranges from 11 to 50%.
  • The number of cardiac devices implanted has increased dramatically together with the number of device-related infections.
  • The rates of cardiac rhythm management device infections increase faster than the implant rate.
  • Infective endocarditis has become more difficult to treat due to a high number of MRSA infections and the increasing number of device infections.
  • Strong evidence supports the use of screening with echocardiography in patients with SAB.

=>      European Society of Cardiology guidelines provide a review of the diagnosis, management and treatment of infective endocarditis2.

References

 

1-  Rasmussen RV. Future Challenges and Treatment of  Staphylococcus aureus Bacteraemia with Emphasis on MRSA. Future Microbiology. 2011;6(1):43-56.

2- Habib G, Hoen B, Tornos P et al.: Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur. Heart J. 2009; 30(19), 2369–2413.